Iqos

Iqos (stylized as IQOS) is a line of heat-not-burn tobacco products manufactured by Philip Morris International. The device is an alternative to traditional cigarettes and is designed to heat specially designed tobacco units called HEETS or HeatSticks, rather than burning them. This process generates a nicotine-containing aerosol with fewer harmful chemicals than cigarette smoke.
History[edit]
Iqos was first introduced in Japan and Italy in 2014. Since then, it has been launched in numerous countries worldwide. The product was developed as part of Philip Morris International's efforts to create a smoke-free future by providing less harmful alternatives to smoking.
Technology[edit]
The Iqos device consists of three main components:
- The Holder: This is the part of the device where the tobacco unit is inserted and heated.
- The Charger: This is used to recharge the holder after each use.
- The Tobacco Units: These are specially designed tobacco sticks that are heated by the holder.
The device heats the tobacco to a temperature of around 350°C, which is significantly lower than the 600°C to 900°C at which traditional cigarettes burn. This lower temperature reduces the levels of harmful chemicals produced.
Health Impact[edit]
While Iqos is marketed as a less harmful alternative to smoking, it is not without risks. The aerosol produced by Iqos contains nicotine, which is addictive, and other potentially harmful chemicals. However, studies have shown that the levels of harmful chemicals are significantly lower than those found in cigarette smoke.
Regulation[edit]
Iqos is subject to various regulations depending on the country. In some regions, it is classified similarly to traditional tobacco products, while in others, it is regulated as a separate category. In the United States, the Food and Drug Administration (FDA) authorized the marketing of Iqos as a modified risk tobacco product in 2020, recognizing that it could help reduce the risk of smoking-related diseases.
Market Presence[edit]
Iqos has gained significant market share in several countries, particularly in Japan, where it has become a popular alternative to traditional cigarettes. The product is also available in many European countries, as well as in Canada, Russia, and other markets.
Controversies[edit]
The introduction of Iqos has not been without controversy. Critics argue that the product may attract non-smokers, particularly young people, and could serve as a gateway to traditional smoking. There are also concerns about the long-term health effects of using heat-not-burn products, which are not yet fully understood.
See Also[edit]
References[edit]
<references group="" responsive="1"></references>
External Links[edit]
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian